Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,796,285 papers from all fields of science
Search
Sign In
Create Free Account
CyVADIC Regimen
Known as:
Cyclophosphamide-Vincristine-Adriamycin-DTIC Regimen
A regimen consisting of cyclophosphamide, vincristine, doxorubicin, and dacarbazine used for the treatment of unresectable soft-tissue sarcoma.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
CYVADIC protocol
Cyclophosphamide
Dacarbazine
Doxorubicin
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Recurrent malignant phyllodes tumor of breast with gastric metastasis
Hsin-Chen Lin
,
Cheng-Wei Chou
Journal of Cancer Research and Practice
2019
Corpus ID: 201663792
Malignant phyllodes tumor of the breast (MPTB) is a rare breast malignancy. Surgery is the primary treatment for this malignant…
Expand
2002
2002
Primitive neuroectodermal tumor of the spermatic cord.
H. Matsumoto
,
Ryo Inoue
,
M. Tsuchida
,
Mutsuo Takahashi
,
K. Naito
Journal of Urology
2002
Corpus ID: 28409471
Review
1997
Review
1997
Freireich's laws in the treatment of sarcomas.
Robert S. Benjamin
Clinical Cancer Research
1997
Corpus ID: 26708976
Review
1983
Review
1983
Infusion Chemotherapy for Soft Tissue Sarcomas
R. Benjamin
,
B. Yap
1983
Corpus ID: 68686378
Adriamycin has formed the backbone of sarcoma chemotherapy since its introduction into clinical practice. The pioneering studies…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE